Summary
We have evaluated Sramek's method of impedance cardiography as a non-invasive way of detecting the cardiovascular effects of drugs. We made cardiovascular measurements using the method during passive tilting and exercise 2 h after the oral administration of atenolol (50 and 100 mg), propranolol (40 and 80 mg), pindolol (5 and 10 mg), and placebo in seven separate studies involving eight healthy male volunteers.
Equivalent doses of the pure antagonists atenolol (β1) and propranolol (β1, β2) produced similar reductions in heart rate, systolic blood pressure, and cardiac index, and increases in stroke volume and total peripheral resistance, particularly during exercise. In contrast the partial agonist pindolol produced increases in heart rate and cardiac index, and reductions in peripheral resistance at rest. During passive tilting and exercise pindolol reduced heart rate, but cardiac output and total peripheral resistance were unchanged except at the highest levels of exercise.
The similar cardiovascular effects of atenolol and propranolol, but differing effects of pindolol, are consistent with reports using other methods of measurement. This suggests that impedance cardiography may have a place in the non-invasive assessment of the cardiovascular effects of drugs.
Similar content being viewed by others
References
Swan HJC, Ganz W (1979) Complications with flow-directed balloon-tipped catheters. Ann Intern Med 91: 494–497
Lysbo Svendsen T, Hartling O, Trap-Jensen J (1979) Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol, and ICI 89, 406 in healthy volunteers. Eur J Clin Pharmacol 15: 223–228
Belz GG, Mathews JH, Graf D, Stern HC, Bachmann R, Belz G, Steinijans VW, Palm D (1985) Dynamic response to intravenous uradipil and dihydralazine in normal subjects. Clin Pharmacol Ther 37: 48–54
Pedersen T, Engbaek J, Ording H, Viby-Mogensen J (1984) Effect of pancuronium on cardiac performance and transmural myocardial perfusion during ketamine anaesthesia. Acta Anaesth Scand 28: 443–446
Goldstein JS, Cannon RO, Zimlichman R, Keiser HR (1986) Clinical evaluation of impedance cardiography. Clin Physiol 6: 235–251
Belz GG, Mathews JH, Beck A, Wagner G, Schneider B (1985) Haemodynamic effects of nicorandil, isosorbide dinitrate, and dihydralazine in healthy volunteers. J Cardiovasc Pharmacol 7: 1107–1112
Toth PD, Demeter RJ, Woods JR, Nyhuis AW, Judy WV (1988) Comparison of the effects of pindolol and atenolol on hemodynamic function in systemic hypertension. Am J Cardiol 62: 413–418
Thomas SHL, Molyneux P, Kelly J, Smith SE (1990) The cardiovascular effects of oral nifedipine and nicardipine: a double-blind comparison in healthy volunteers using transthoracic bioimpedance cardiography. Eur J Clin Pharmacol 39: 233–240
Kubicek WG, Karnegis JN, Patterson RP, Witsoe DA, Mattson RH (1966) Development and evaluation of an impedance cardiac output system. Aerospace Med 37: 1208–1212
Bache RJ, Harley A, Greenfield JC Jr (1969) Evaluation of thoracic impedance plethysmography as an indicator of stroke volume in man. Am J Med Sci 258: 100–113
Van Der Water JM, Thourn LG, Watanabe LS, Lappen RS (1971) Bioelectrical impedance: new developments and clinical application. Arch Surg 102: 541–547
Donovan KD, Dobb GJ, Woods WP, Hockings BE (1986) Comparison of transthoracic electrical bioimpedance and thermodilution methods for measuring cardiac output. Crit Care Med 14: 1038–1044
Sramek BB, Rose DM, Miyamoto A (1981) Stroke volume equation with a linear base impedance model and its accuracy as compared to thermodilution and magnetic flowmeter techniques in humans and animals. Proceedings of the Sixth International Conference on Electrical Bioimpedance, Zadar, Yugoslavia pp 28–41
Appel PL, Kram HB, Macabee J, Fleming AW, Shoemaker WC (1986) Comparison of measurements of cardiac output by bioimpedance and thermodilution in critically ill patients. Crit Care Med 14: 933–935
Bernstein DP (1986) Continuous real time monitoring of stroke volume and cardiac output by thoracic electrical bioimpedance. Crit Care Med 14: 898–900
Goli VD, Teague SM, Prasad R, Harvey J, Voyles WF, Olsen EG, Schechter E, Thadani U (1988) Noninvasive evaluation of aortic stenosis severity utilizing Doppler ultrasound and electrical bioimpedance. J Am Coll Cardiol 11: 66–71
Jacob F, Marriot J, Frisoni A, Perrier JF, Voltz C, Strub P, Ethevenot G (1988) Mésure du debit cardiaque par bioimpedance électrique thoracique ou par thermodilution. Ann Fr Anaesth Reanim 7: 264–267
Saladin V, Zussa C, Risica G, Michielon P, Paccagnella A, Cipolotti G, Simini G (1988) Comparison of cardiac output estimation by thoracic electrical bioimpedance, thermodilution, and Fick methods. Crit Care Med 16: 1157–1158
Spinale FG, Reines HD, Crawford FA Jr (1988) Comparison of bioimpedance and thermodilution methods for determining cardiac output: Experimental and clinical studies. Ann Thorac Surg 45: 421–425
Northridge DB, Findlay IN, Wilson J, Henderson E, Dargie HJ (1990) Noninvasive determination of cardiac output by Doppler echocardiography and electrical impedance. Br Heart J 63: 93–97
McDevitt DG (1977) The assessment of β-adrenoceptor blocking drugs in man. Br J Clin Pharmacol 4: 413–425
De Plaen F, Amery A, Reybrouk T (1976) Comparative potency of atenolol and propranolol as β adrenergic blocking agents in man. Eur J Clin Pharmacol 10: 297–303
Carruthers SG (1982) Cardiac dose-response relationships of oral and intravenous pindolol. Br J Clin Pharmacol 13: 193S-198S
Bernstein DP (1986) A new stroke volume equation for thoracic electrical bioimpedance: theory and rationale. Crit Care Med 14: 904–909
Mohapatra SN (1981) Non-invasive cardiovascular monitoring by electrical impedance technique. Pitman, London
Kinnen E (1970) Cardiac output from transthoracic impedance variations. Ann NY Acad Sci 170: 747–756
Secher NJ, Thomsen A, Arnsbo P (1977) Measurement of rapid changes in cardiac stroke volume. Acta Anaesth Scand 21: 353–358
Balasubramanian V, Mathew OP, Behl A, Tewari SC, Hoon RS (1974) Electrical impedance cardiogram in derivation of systolic time intervals. Br Heart J 40: 268–275
Stern HC, Wolf GC, Belz GC (1985) Comparative measurement of left ventricular ejection time by mechano-, echo-, and electrical impedance cardiography. Arzneim-Forsch 35: 1582–1586
Thomas SHL (1991) Comparison of the cardiovascular effects of nifedipine and nicardipine in the presence of atenolol. Eur J Clin Pharmacol 41: 201–206
Duncan DB (1955) Multiple range and multiple F tests. Biometrics 11: 1–42
George CF (1975) problems in assessing β-adrenoceptor antagonism in man. Br J Clin Pharmacol 2: 3–4
Waller DG (1990) β-adrenoceptor partial agonists: a renaissance in cardiovascular therapy? Br J Clin Pharmacol 30: 157–171
Lund Johansen P (1976) Haemodynamic long-term effects of a new β adrenoceptor blocking drug, atenolol (ICI 66082) in essential hypertension. Br J Clin Pharmacol 3: 445–451
Frisk-Holmberg M, Jorfeldt L, Juhlin-Dannfeldt A (1977) Influence of alprenolol on haemodynamic and metabolic responses to prolonged exercise in subjects with hypertension. Clin Pharmacol Ther 21: 675–684
Leenen FHH (1979) Possible significance of the pharmacological differentiation of β-blockers for therapy of hypertension. Br J Clin Pharmacol 7: 173S-184S
Leenan FHH, Cees HM, Coenan M, Zonderland M, Maas AJH (1980) Effects of cardioselective and non selective β-blockers on dynamic exercise performance in mildly hypertensive men. Clin Pharmacol Ther 28: 12–21
Van Baak MA, Koene FMM, Verstappen FTJ (1988) Exercise haemodynamics and maximal exercise capacity during β-adrenoceptor blockade in normotensive and hypertensive subjects. Br J Clin Pharmacol 25: 169–178
Frei F, Imhof P, Dubach UC (1974) Effects of alpha-and beta-blockade on systolic time intervals. Eur J Clin Pharmacol 7: 1–10
Van Herick R, Aronow WS (1978) Effects of oxprenolol and propranolol on systolic time intervals. Clin Pharmacol Ther 24: 678–682
McSorley PD, Warren DJ (1978) Effects of propranolol and metoprolol on the peripheral circulation. Br Med J 2: 1598–1600
Weil C, Waite R (1982) Haemodynamic differences in untreated hypertension and hypertension treated with various β-adrenoceptor antagonists. Br J Clin Pharmacol 13: 279S-283S
Man in 't Veld AJ, Schalekamp MADH (1982) How intrinsic sympathomimetic activity modulates the haemodynamic response to β adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism. Br J Clin Pharmacol 13: 245S-257S
Fitscha P, Tiso B, Meisner W, Spitzer D (1982) The effect of intrinsic sympathomimetic activity of β-adrenoceptor blockers on circadian heart rate. Br J Clin Pharmacol 13: 211S-215S
Tsukiyama H, Otsuka K, Higuma K (1982) Effects of β-adrenoceptor antagonists on central haemodynamics in essential hypertension. Br J Clin Pharmacol 13: 269S-278S
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thomas, S.H.L., Cooper, R.C., Ekwuru, M. et al. Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiography. Eur J Clin Pharmacol 42, 47–53 (1992). https://doi.org/10.1007/BF00314919
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00314919